When found early, cancer is often effectively treated or even cured. We aim to integrate early-stage cancer diagnosis into the nation-funded health examination, helping health professions to give accurate information to cure the disease effectively
 

SOL Bio is planning to carry out research and development of in vitro diagnostic products for immuno-isolation and analysis of exosomes, along with CDx (companion diagnostics) products and platform service businesses
 

SOL Bio has five types of unique technologies (Smart Operation Linkage; 'SOL') in the form of intellectual property or know-how that can meet unmet needs in the field of in vitro diagnostics, including companion diagnostics
 

These technologies are co-diagnosis platform technologies, which are expected to substantially contribute to the treatment of various acute and chronic diseases (cancer, inflammation, diabetes, etc.) in the future, resulting in significant corporate value growth